Noile-Immune Biotech Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 26, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	7,318	7,361	9,175	-	-	-
Market Cap Growth	-14.31%	-19.77%	-	-	-	-
Enterprise Value	2,853	2,645	3,519	-	-	-
Last Close Price	169.00	170.00	212.00	-	-	-
PS Ratio	1045.43	1051.61	29.03	-	-	-
PB Ratio	1.63	1.56	1.61	-	-	-
P/TBV Ratio	1.63	1.56	1.61	-	-	-
EV/Sales Ratio	-	377.90	11.14	-	-	-
Asset Turnover	0.00	0.00	0.06	0.14	0.03	-
Inventory Turnover	6.18	4.86	3.65	2.00	3.14	-
Quick Ratio	49.69	68.58	65.36	13.49	52.41	37.13
Current Ratio	50.07	69.20	66.48	13.68	52.81	37.99
Return on Equity (ROE)	-17.57%	-18.52%	-22.63%	-9.10%	-23.44%	-
Return on Assets (ROA)	-12.09%	-12.63%	-9.31%	-1.49%	-13.79%	-
Return on Capital (ROIC)	-12.35%	-12.84%	-9.71%	-1.56%	-14.12%	-
Earnings Yield	-11.81%	-13.10%	-12.32%	-	-	-
Buyback Yield / Dilution	-2.14%	-4.41%	-5.87%	-2.23%	-7.89%	-

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.